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Bcl-2 family proteinScutellaria baicalensis (SB) and SB-derived polyphenols possess anti-proliferative activities in several cancers,
including pancreatic cancer (PaCa). However, the precise molecular mechanisms have not been fully deﬁned.
SB extract and SB-derived polyphenols (wogonin, baicalin, and baicalein) were used to determine their anti-
proliferative mechanisms. Baicalein signiﬁcantly inhibited the proliferation of PaCa cell lines in a dose-
dependent manner, whereas wogonin and baicalin exhibited a much less robust effect. Treatment with
baicalein induced apoptosis with release of cytochrome c from mitochondria, and activation of caspase-3 and
-7 and PARP. The general caspase inhibitor zVAD-fmk reversed baicalein-induced apoptosis, indicating a
caspase-dependent mechanism. Baicalein decreased expression of Mcl-1, an anti-apoptotic member of the
Bcl-2 protein family, presumably through a transcriptional mechanism. Genetic knockdown of Mcl-1 resulted
in marked induction of apoptosis. The effect of baicalein on apoptosis was signiﬁcantly attenuated by Mcl-1
over-expression, suggesting a critical role of Mcl-1 in this process. Our results provide evidence that baicalein
induces apoptosis in pancreatic cancer cells through down-regulation of the anti-apoptotic Mcl-1 protein.e National Institutes of Health
avid Geffen School of Medicine
s Angeles, CA 90095, USA. Tel.:
l rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Pancreatic cancer (PaCa) is the fourth leading cause of cancer-
related death in the United States. An estimated 21,370 men and
21,770 women will be diagnosed with pancreatic cancer in the year
2010 in the United States, and the majority of these patients will die
within 6 months [1]. Gemcitabine has been considered the standard
chemotherapeutic agent in the treatment of PaCa. However, studies
using gemcitabine either as monotherapy or as combination therapy
with cytotoxic or molecular targeted agents revealed only a marginal
overall survival beneﬁt [2]. One reason for the dismal prognosis of
patients with pancreatic cancers and the inefﬁciency of most chemo-
and radio-therapeutic regimens is the strong resistance of PaCa cells
to cell death. The resistance to apoptotic cell death is often caused by
the up-regulation of anti-apoptotic molecules of the Bcl-2 protein
family. The identiﬁcation of operative anti-apoptotic mechanisms and
the development of potent and non-toxic strategies to overcome theanti-apoptotic mechanisms in PaCa cells are of utmost importance to
improve the outcome of PaCa patients.
The Bcl-2 protein family consists of anti-apoptotic proteins (Bcl-2,
Bcl-xL, Bcl-w, and Mcl-1) and pro-apoptotic proteins that include
multi-domainmolecules Bak and Bax, and the BH3-only proteins Bad,
Bid, Bim, Puma, and Noxa [3]. Mcl-1 is expressed in a wide variety of
cell types, and its expression is highly induced by survival and
differentiation signals such as cytokines and growth factors [4].
WhileMcl-1 is only weakly expressed in the exocrine pancreas [5], in
PaCa Mcl-1 is over-expressed in 90% of invasive ductal adenocarci-
nomas [6]. Several reports describe that Mcl-1 expression is
correlated with cancer cell resistance to chemotherapy and genetic
inhibition of Mcl-1 induces apoptosis and enhances drug- and
radiation-mediated apoptosis in several types of cancer, including
PaCa [7–10].
Scutellaria baicalensis (SB) is a member of the Lamiaceae or mint
family and is known as Chinese skullcap (or Huang Qin) and as
Japanese Ogon. SB is a widely used herb in traditional Chinese and
Japanese medicine with anti-inﬂammatory properties [11]. The root is
rich in ﬂavonoids with over 50 different compounds currently
identiﬁed. It has been reported that SB or SB-derived polyphenols,
particularly baicalein and wogonin, have potent anti-tumor activity in
several cancers [12–16]. Baicalein was recently reported to reduce
Bcl-2 and Mcl-1 protein expression in PaCa cells [15], but the precise
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in general and to the effect of baicalein were not investigated.
In this study, we provide evidence that baicalein induces apoptosis
by reducing the expression of the pro-survival Mcl-1, at least partially
via a transcriptional mechanism. Furthermore, our data highlight the
importance of Mcl-1 as a crucial mediator of PaCa cell resistance to cell
death.2. Materials and methods
2.1. Reagents
Antibodies against caspase-3 (total and cleaved), caspase-7 (total
and cleaved), PARP (total and cleaved), Bcl-2, Bcl-xL, Mcl-1, Bad, Bim,
Bid, PUMA, Bax, cytochrome c, cytochrome c oxidase subunit IV (cox-
IV), and GAPDH were purchased from Cell Signaling Technology
(Danvers, MS). Bak antibodies were obtained from Abcam (Cam-
bridge, MA). The pan-caspase inhibitor zVAD-fmk was from Calbio-
chem (Gibbstown, NJ). The proteasome inhibitor MG132 was from
Assay Designs (Ann Arber, MI). SB extract (powder)was from CORTEX
Scientiﬁc Botanicals (Ojai, CA). Baicalin, baicalein, and wogonin were
purchased from ChromaDex (Irvine, CA). Other reagents were
obtained from common commercial sources.2.2. Cell culture
The human PaCa cell lines, BxPC-3, HPAF-II, Capan-2, AsPc-1, MIA
PaCa-2, and Panc-1 were obtained from the American Type Culture
Collection (ATCC, Rockville, MD) and cultured as described previously
[17].2.3. Preparation of SB extract and SB-derived polyphenols
The SB powder was dissolved in serum-free medium as described
previously [12]. Baicalin, baicalein, and wogonin were dissolved in
DMSO (Sigma) to produce 50 mM stock solutions that were aliquoted
and stored at −20 °C prior to use. The stock solutions were diluted
with culture media to the indicated concentrations (ﬁnal DMSO
concentration 0.1%).2.4. Cell proliferation
To examine the effect of SB and SB-derived polyphenols on cell
proliferation, we used 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide (MTT) assay and 5-bromo-2′-deoxy-uridine
(BrdU) Labeling and Detection Kit III (Roche Applied Science,
Mannheim, Germany). Cells (1×104/well) were seeded into 96-well
tissue culture plates and incubated at 37 °C overnight. Medium was
changed to serum-free condition and incubated for another 4 h. Cells
were subsequently treatedwith SB or SB-derived polyphenols for 48 h
in serum-free medium. Absorbance was measured according to the
manufacturer's instructions.2.5. DNA fragmentation
DNA fragmentation was measured as described previously [18].
Brieﬂy, cells were seeded into 6-well culture plates and incubated at
37 °C overnight. Medium was changed to serum-free condition and
incubated for another 4 h. Cells were then treated with baicalein for
24 h. DNA fragmentation was analyzed by the Cell Death Detection
ELISAPlus kit (Roche) according to themanufacturer's instructions. The
extent of apoptosis was presented as an enrichment factor (mU of the
treated cells/mU of the non-treated cells).2.6. Hoechst 33258 staining
To assess changes in nuclear morphology during apoptosis,
staining using ﬂuorescent Hoechst 33258 (Invitrogen, Carlsbad, CA)
was performed. Cells were seeded into a Lab-Tek® II Chamber Slide™
System (Nalgene Nunc International, Naperville, IL). Baicalein was
added to the medium and incubated for 24 h. Cells were ﬁxed with 4%
paraformaldehyde and stained with Hoechst 33258. Slides were
mounted with VECTASHIELD (Vector Laboratories Inc., Burlingame,
CA), and were observed under a ﬂuorescence microscope (Nikon,
Eclipse 90i, Tokyo, Japan). Apoptotic nuclei were identiﬁed by
morphologic changes such as chromatin condensation and nuclear
fragmentation. Total nuclei and apoptotic nuclei were counted
respectively by NIS-Elements AR software (Nikon). This method
allows the assessment of apoptosis through identiﬁcation of nuclear
changes and avoids possible artifacts in membrane morphology
caused by cell detachment, which is detected by Annexin/PI and ﬂow
cytometry.
2.7. Cell lysates
Total cell lysates were collected as described previously [19].
Protein concentration was measured using the BCA Protein Assay Kit
(Pierce, Rockford, IL). For preparation of mitochondrial and cytosolic
fractions, cells were re-suspended in a lysis buffer as described
previously [20], allowed to swell for 30 min at 4 °C, and then
disrupted by 80 strokes with a Dounce homogenizer. Homogenates
were centrifuged at 1000×g for 5 min to pellet nuclei and cell debris.
Supernatants were centrifuged at 16,000×g for 30 min, and the
cytosolic fractions (supernatants) were collected. Pellets (heavy
membranes enriched with mitochondria) were lysed in RIPA buffer.
To determine the quality of cytosolic and mitochondrial separation,
both fractions were assessed by immunoblotting for the mitochon-
drial marker cox-IV.
2.8. Western blot analysis
Western blot was performed as described previously [21]. Protein–
antibody complexes were visualized with the SuperSignal West Pico
or SuperSignal West Femto Chemiluminescent Substrate (Pierce).
2.9. Caspase 3 and 7 activity
Caspase-3 and -7 activity was measured by the caspase-Glo™ 3/7
assay (Promega, Madison, WI). Cells (1×104/well) were seeded into
96-well tissue culture plates and incubated overnight at 37 °C. Cells
were treated with the indicated doses of baicalein for 24 h. 100 μl of
the caspase-Glo™ 3/7 reagent was added to each well and incubated
at room temperature for 30 min, and the luminescence in each well
was measured using a luminometer.
2.10. Immunoprecipitation
Cells were lysed in NP-40 buffer (150 mM sodium chloride, 1% NP-
40, 50 mM Tris–HCl, protease inhibitor cocktail) for 30 min on ice and
clariﬁed by centrifugation at 16,000×g for 15 min at 4 °C. 500 μg of
proteinwas subjected to overnight immunoprecipitationwith speciﬁc
antibodies at 4 °C using Catch and Release Reversible Immunopre-
cipitation kit (Millipore, Billerica, MA). Unbound proteins were
washed and bound proteins on the column were eluted, after which
samples were loaded for Western blot.
2.11. RNA interference
siGENOME SMARTpool against Bcl-2, Bcl-xL, Mcl-1, and Bad aswell
as siGENOME Non-Targeting Pool (#2) were purchased from
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culture plates and incubated overnight at 37 °C without antibiotics.
The following day, cells were transfected with speciﬁc siRNA using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the
manufacturer's instructions. 5 h after transfection, medium was
changed to serum free DMEM or RPMI medium and incubated for
another 24 h.
2.12. RNA isolation and quantitative real-time RT-PCR
Total RNA was extracted as described previously [22]. RNA (1 μg)
was reverse transcribed using the iScript cDNA synthesis kit (Bio-
Rad). Real time RT-PCR was performed on an iQ5 Real-Time PCR
Detection System (Bio-Rad, Hercules, CA) using iQ™ SYBR Green
Supermix (Bio-Rad) and speciﬁc intron-spanning primers. Primer
pairs were as follows: Mcl-1 (accession number: NM_021960)
forward: TTAAACAAAGAGGCTGGGATG (exon 2–3) and reverse:
ACCAGCTCCTACTCCAGCAA (exon 3), and GAPDH (accession number:
NP_002037) forward: GACATCAAGAAGGTGGTGAAGC (exon 8) and
reverse: GTCCACACCCTGTTGCTGTAG (exon 9). Ampliﬁcation of
unspeciﬁc products was excluded by melt curve analysis and agarose
gel electrophoresis of PCR products. Gene expression was normalized
to GAPDH as a housekeeping gene and calculated using the ΔΔCT
method.
2.13. Plasmid vector transfection
BxPC-3 cells were seeded into 6-well tissue culture plates and
incubated overnight at 37 °C without antibiotics. The following day,
cells were transfected with plasmid vector encoding human Mcl-1
[23] (pCDNA3.1-hMcl-1, Addgene) or control vector (pCDNA3.1,
Invitrogen) using Lipofectamine 2000 (Invitrogen) according to the
manufacturer's instructions. 5 h after transfection, medium was
changed to 10% serum DMEM or RPMI medium and incubated for
another 48 h. Stable lines were selected by adding G418 (Sigma) into
the medium.
2.14. Statistical analysis
Data are presented as means±SD, and statistical comparisons
were made using the Student's t test for paired observations.
Comparisons of more than two groups were made by a one-way
ANOVA with post hoc Holm–Sidak analysis for pairwise comparisons
and comparisons versus control. An alpha value of 0.05 was used to
determine signiﬁcant differences. All statistics were done in SigmaStat
3.1 (Systat Software, Inc.).
3. Results
3.1. SB and SB-derived polyphenols reduce proliferation of pancreatic
cancer cells
To conﬁrmwhether SB and SB-derived polyphenols can inhibit cell
growth in PaCa cells, six PaCa cell lines were exposed to whole SB
extract and SB-derived polyphenols for 48 h and cell growth was
measured by MTT and BrdU assay. Whole SB extract reduced
proliferation of all six PaCa cell lines (with varying degrees of
differentiation) in a dose-dependent manner in both assays (Fig. 1A).
We then compared the growth inhibitory effects of three individual
SB-derived polyphenols (wogonin, baicalin, and baicalein) in four
PaCa cell lines (ranging from undifferentiated to moderately/well
differentiated cell lines). In both MTT and BrdU assays, baicalein
displayed the most robust growth inhibitory effect compared to
wogonin and baicalin (Fig. 1B and C). This effect was most prominent
in BxPC-3 cells.3.2. Baicalein induces apoptosis in pancreatic cancer cells
To elucidate the mechanism, by which baicalein reduces PaCa cell
growth, we determined whether the decrease in cell growth by
baicalein was mediated by the induction of apoptotic cell death. We
ﬁrst measured DNA fragmentation, a hallmark of apoptosis. As shown
in Fig. 2A, baicalein induced DNA fragmentation in a dose-dependent
manner in all four cell lines. Induction of apoptosis was further
conﬁrmed by Hoechst 33258 staining. Baicalein signiﬁcantly and
dose-dependently led to morphological changes in cell nuclei
(chromatin condensation and nuclear fragmentation) consistent
with DNA fragmentation and apoptosis (Fig. 2B and C).
3.3. Baicalein induces apoptosis through a caspase-dependent pathway
Having demonstrated that baicalein induced apoptosis, we next
investigated whether this effect was mediated by activation of
caspases. Exposure of BxPC-3 or MIA PaCa-2 cells to baicalein resulted
in a time-dependent cleavage of caspase-3, -7, and PARP (Fig. 3A).
These events were readily observed after 8–12 h of treatment and
peaked at 24 h. Baicalein also dose-dependently induced cleavage of
caspase-3, -7, and PARP (Fig. 3B). We further conﬁrmed caspase-3/7
activity by ELISA (Fig. 3C), which was consistent with the Western
blot results. Furthermore, the pan-caspase inhibitor zVAD-fmk
reversed baicalein-induced DNA fragmentation and cleavage of
PARP (Fig. 3D and E) in a dose-dependent manner, indicating that
the induction of apoptosis by baicalein in PaCa cells proceeds through
the activation of caspases.
3.4. Baicalein reduces the expression of the anti-apoptotic Bcl-2 family
member Bcl-2 and Mcl-1
Since the anti-apoptotic Bcl-2 family proteins play a major role in
the protection against DNA damage-induced apoptosis [23], we
sought to determine the endogenous expression of anti-apoptotic
Bcl-2 family proteins, as well as the effect of baicalein on anti-
apoptotic Bcl-2 family proteins. Mcl-1 was detected in BxPC-3, MIA
PaCa-2, HPAF-II, Capan-2, and Panc-1 cells, but was not detected in
AsPc-1 cells (Fig. 4A). Bcl-2 was expressed in MIA PaCa-2 and Panc-1
cells, but virtually undetectable in other cell lines. Bcl-xL was
expressed in all six cell lines.
Baicalein signiﬁcantly reduced the expression of Bcl-2 andMcl-1 in
a dose-dependent manner, but had no effect on Bcl-xL expression
(Fig. 4B). The doses of baicalein needed to reduce Mcl-1 and Bcl-2
expression closely matched those sufﬁcient to induce apoptosis. To
determine the kinetics of baicalein, we measured the time-dependent
decrease in Mcl-1 and Bcl-2 expression. The decrease in Mcl-1
expression in BxPC-3 and MIA PaCa-2 cells was detected after 4 h of
baicalein treatment, whereas the reduction of Bcl-2 in MIA PaCa-2
cells was only detectable after 12 h of treatment (Fig. 4C). This is
consistent with previous studies showing that Mcl-1 mRNA and
protein exhibit a short half-life and the expression levels depend on
the balance of de novo synthesis and degradation [25,26].
It has been reported that Mcl-1 expression is regulated at the
transcriptional level by a variety of transcriptional factors [27,28]. In
addition, post-translational regulation of Mcl-1 expression, e.g.
through proteosomal degradation, has been documented [29]. To
investigate the transcriptional regulation of Mcl-1, we performed
real-time RT-PCR. Baicalein treatment dose-dependently reduced
Mcl-1 mRNA levels (Fig. 4D). In addition, the proteosome inhibitor
MG132 (0.2 μM for 1 h) increased Mcl-1 protein expression, suggest-
ing a post-transcriptional regulation of Mcl-1 expression through
proteosomal degradation. Importantly, baicalein was capable of
reducing Mcl-1 protein expression in MG132-treated cells (Fig. 4E).
Collectively, these results strongly suggest that the reduction of Mcl-1
expression by baicalein involves at least a transcriptional mechanism.
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Fig. 1. The effect of SB and SB-derived polyphenols on cell proliferation. A, Six human pancreatic cancer cell lines were treated with the indicated concentrations of SB extract for 48 h
and cell proliferation was measured by MTT assay (left) and BrdU assay (right). Results are presented as mean±SD (bars). Four human pancreatic cancer cells were then exposed to
three puriﬁed polyphenols (baicalin, baicalein, and wogonin) for 48 h and cell proliferation was measured by MTT assay (B) and BrdU assay (C).
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dria after 12 h treatment (Fig. 4F).
3.5. Apoptosis-inducing effect of baicalein is mediated by Mcl-1
Since we observed a close correlation between baicalein-induced
apoptosis and decrease in Mcl-1 expression, we sought to determinethe role of Mcl-1 in PaCa cell survival and baicalein-induced apoptosis
in more detail. As shown in Fig. 5A, knock-down of Mcl-1 expression
by siRNA signiﬁcantly induced apoptosis, whereas Bcl-2 or Bcl-xL
knock-down had a much weaker effect on apoptosis. In addition, Mcl-
1 knock-down strongly induced cleavage of caspase-3, -7 as well as
PARP, while Bcl-2 or Bcl-xL knock-down showed no or only a slight
effect on caspase and PARP cleavage (Fig. 5B).
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Fig. 2. The effect of baicalein on cell apoptosis. A, Cells were seeded in 6-well plates and
treated with baicalein for 24 h, after which DNA fragmentation was measured. Increase
in apoptosis (DNA fragmentation) is presented as enrichment factor. *pb0.05. B,
Changes in nuclear morphology weremeasured by Hoechst 33258 staining as described
in Materials and methods. *pb0.05. C, Representative images of Hoechst 33258 staining
in BxPC-3 cells. Arrowheads show apoptotic cells as identiﬁed by morphologic changes
such as chromatin condensation and nuclear fragmentation.
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principal mechanism of baicalein-induced apoptosis. Cells were
treated for 24 h with the indicated concentrations of baicalein 24 h
after siRNA transfection. Baicalein induced apoptosis 2.6-fold in BxPC-
3 cells transfected with control siRNA, while in BxPC-3 cells
transfected with Mcl-1 siRNA, baicalein induced apoptosis only by
1.2-fold (pb0.01). Similarly, in MIA PaCa-2 cells, baicalein induced
apoptosis in control siRNA and Mcl-1 siRNA transfected cells by 4.7and 1.3-fold (pb0.01), respectively (Fig. 5C). These data clearly
suggest that the apoptosis-inducing effect of baicalein is mediated by
Mcl-1.
Since siRNA-mediated knock-down of Bcl-2 did not induce
apoptosis, but baicalein reduced Bcl-2 as well as Mcl-1 in MIA PaCa-
2 cells, we measured the effect of simultaneous knock-down of Mcl-1
and Bcl-2 in MIA PaCa-2 cells. However, there was no additional effect
compared to Mcl-1 knock-down alone (Fig. 5D). These results suggest
that Bcl-2 down-regulation by baicalein did not play an important role
on baicalein-induced PaCa apoptosis. In addition, double knock-down
of Mcl-1 and Bcl-xL showed amore robust induction of apoptosis than
Mcl-1 knock-down alone, while single knock-down of Bcl-xL did not
signiﬁcantly induce apoptotic cell death in MIA PaCa-2 cells (Fig. 5D).
Since the expression of Mcl-1 in AsPC-1 cells was not detected, we
used AsPC-1 cells to further conﬁrm the importance of Mcl-1 in
protection against baicalein-induced apoptosis. As shown in Fig. 5E,
the apoptosis-inducing effect of baicalein in AsPC-1 cells was much
less robust than in Mcl-1 positive MIA PaCa-2 cells. Finally, we
generated stable, Mcl-1 over-expressing BxPC-3 and MIA PaCa-2 cells
as described in Materials and methods. In control-vector transfected
BxPC-3 andMIA PaCa-2 cells, baicalein induced DNA fragmentation by
13.5±0.3 and 17.1±0.2, respectively. On the other hand, baicalein
induced DNA fragmentation in Mcl-1 over-expressing BxPC-3 and
MIA PaCa-2 cells signiﬁcantly less robust by 7.6±0.1 and 10.8±0.3,
respectively (Fig. 5F). Taken together, these results further emphasize
the critical role of Mcl-1 on baicalein-induced apoptosis in PaCa.
3.6. The effect of baicalein on pro-apoptotic Bcl-2 proteins
Since it has been reported that the pro-apoptotic Bcl-2 family
proteins control cell death cooperatively with anti-apoptotic Bcl-2
family proteins, we next measured which pro-apoptotic Bcl-2 family
proteins may play a role on baicalein-induced apoptosis. In this
context, we ﬁrst measured the endogenous expression of pro-
apoptotic Bcl-2 family proteins. The expression of pro-apoptotic Bcl-
2 family proteins varied between the cell lines and was in no
correlation with baicalein sensitivity (Fig. 6A). Immunoprecipitation
showed that Mcl-1 endogenously binds to Bim, Bak, and Bid, whereas
no binding with Bax, Bad, and PUMA was detected (Fig. 6B). Next, we
measured the effect of baicalein on the expression of pro-apoptotic
Bcl-2 family proteins. Baicalein clearly reduced Bim and PUMA
expression, whereas it induced Bad expression. Increased Bad
expression by baicalein was thereby associated with increased Bad
phosphorylation (Ser112), which is important for translocation of Bad
from the mitochondria to the cytosol (not shown). No changes of Bak,
Bax, and Bid expressions were observed (Fig. 6C). To conﬁrm whether
the effect of baicalein on pro-apoptotic protein expression correlated
withMcl-1 down-regulation, cells were transfected withMcl-1 siRNA,
after which changes in pro-apoptotic proteins were measured. Of
note, Mcl-1 knock-down did not change expression of any pro-
apoptotic proteins (Fig. 6D), suggesting that the effect of baicalein on
pro-apoptotic proteins did not correlate with Mcl-1 down-regulation.
Finally, Bad knock-down by siRNA had no effect on baicalein-induced
apoptosis (Fig. 6E). This together with the increased phosphorylation
of Bad by baicalein (thereby counteracting the pro-apoptotic function
of Bad) strongly indicated that the pro-apoptotic effect of baicalein did
not involve Bad.
4. Discussion
Previous reports have demonstrated that SB and SB-derived
polyphenols reduce the growth of several cancer cell lines in vitro
[12–16], but their anti-proliferative effect in PaCa cells is less
explored. The results of this study showed that SB extract and all
SB-derived polyphenols reduced the proliferation of PaCa cell lines in
a dose-dependent manner. While baicalin (10% of raw material, ref.
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1470 H. Takahashi et al. / Biochimica et Biophysica Acta 1813 (2011) 1465–1474[4]) had only a minimal effect on PaCa growth, its aglycone baicalein
(5% of raw material) had the most potent growth inhibitory effect,
consistent with a previous report in multiple myeloma cell lines [16].In general, the growth-inhibitory effect was more clearly seen in the
BrdU assay, which detects changes in DNA synthesis, compared to the
MTT assay, whichmeasures cell viability. Although baicalein wasmost
00.2
0.4
0.6
0.8
1
1.2
0 5 15 50
M
cl
-1
/G
A
PD
H
 (r
ati
o)
baicalein (µM)
BxPC-3 MIA PaCa-2
baicalein (µM): 15150 05 5 50
MIA PaCa-2BxPC-3B
Bcl-xL
Bcl-2
GAPDH
Mcl-1
Mcl-1
GAPDH
BxPC-3 MIA PaCa-2C
baicalein (µM): - - + - +    - + - + - + - - + - + - +    - + - +
A
Bcl-2
Bcl-xL
Mcl-1
Anti-apoptotic
GAPDH 
B H M P C A
0
200
400
600
800
M
cl
-1
/G
A
PD
H
 (%
)
0
50
100
150
200D
*
*
*
E
baicalein: - - +      +                - - +      +
MG132: - + - + - + - +
MIA PaCa-2BxPC-3
GAPDH 
Mcl-1
Bcl-2
F
cytochrome c
MIA PaCa-2
Cox IV
cytochrome c
cytosolic
mitochondria
GAPDH
Cox IV
baicalein (µM): 5 15 50
BxPC-3
0h 2h 4h 8h 12h 24h 0h 2h 4h 8h 12h 24h
0 5 15 0
Fig. 4. Baicalein modulated expression of a subset of anti-apoptotic Bcl-2 family proteins and induced cytochrome c release from mitochondria. A, Endogenous expression of anti-
apoptotic Bcl-2 family proteins in BxPC-3 (B), HPAF-II (H), MIA PaCa-2 (M), Panc-1 (P), Capan-2 (C), and AsPc-1 (A) cells. B, Cells were treated with baicalein for 24 h and changes in
anti-apoptotic Bcl-2 family protein expression were measured. C, Cells were treated with 5 μM (BxPC-3) or 15 μM (MIA PaCa-2) baicalein for the indicated times and the expression
of Mcl-1 and Bcl-2 was measured. D, Cells were treated with baicalein for 2 h, after which total RNA was isolated and Mcl-1 mRNA was quantiﬁed by real time RT-PCR. Values
represent the means±SD for three independent experiments performed in triplicate and are expressed as a fold increase relative to the non-treated cells. *pb0.01. E, Cells were pre-
treated with the proteasome inhibitor MG132 (0.2 μM) for 1 h, followed by 5 μM (BxPC-3) or 15 μM (MIA PaCa-2) baicalein for another 6 h. Mcl-1 protein expression was measured
by Western blot (lower panel) and the signal density was measured by Image J software and was expressed as Mcl-1/GAPDH (%) (upper panel). F, Cells were treated with the
indicated concentrations of baicalein for 12 h, after which mitochondrial and cytosolic fraction were separated as described inMaterials and methods. Levels of cytochrome c in each
subfraction were measured by Western blot. Cox IV and GAPDH served as loading controls for mitochondrial and cytosolic fraction, respectively.
1471H. Takahashi et al. / Biochimica et Biophysica Acta 1813 (2011) 1465–1474effective in Kras wildtype BxPC-3 cells, it is important to note that it
also inhibited growth of Kras mutated pancreatic cancer cells at
concentrations that can be achieved in vivo in mice fed a diet
supplemented with 1% SB extract for 8 weeks (manuscript submit-
ted). Furthermore, Bonham et al. reported that most of the activity
seen with the SB extract could be attributed to baicalein in prostate
cancer cells [14]. Based on these reports and our study, we decided to
investigate the mechanisms of baicalein-induced growth inhibition in
PaCa cells.
Anti-apoptotic Bcl-2 family proteins play an important role in
response to a variety of death stimuli [24]. Mcl-1 is one of the anti-
apoptotic Bcl-2 family proteins, and its over-expression has been
reported in a variety of hematopoietic, lymphoid, and some solid
tumors including PaCa [6,28]. In these cancers, Mcl-1 plays a key role
in the resistance to conventional chemotherapy. Importantly, somepapers showed that Bcl-2 or Bcl-xL knock-down by siRNA is not
enough to promote apoptosis, but Mcl-1 knock-down alone can
clearly induce apoptosis in melanoma and chronic lymphocytic
leukemia cells [30,31]. From these reports, Mcl-1 is considered to be
a promising therapeutic target in several cancers, but the importance
of Mcl-1 in PaCa is unknown. In this context, we ﬁrst conﬁrmed the
expression of anti-apoptotic Bcl-2 family proteins in six PaCa cell lines
ranging from undifferentiated to well differentiated cell lines. Mcl-1
was expressed in ﬁve PaCa cell lines, but Bcl-2 was detected in only
MIA PaCa-2 and Panc-1 cells. Miyamoto et al. reported that Bcl-2
protein was strongly expressed in MIA PaCa-2 and Panc-1 cells [6].
Others showed that Bcl-2 protein was strongly expressed in BxPC-3
cells, but weakly expressed in Panc-1 cells [32]. The exact reasons for
this discrepancy are unclear, but different culture conditions, cell
passages, and different antibodies may be potential causes. We
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1472 H. Takahashi et al. / Biochimica et Biophysica Acta 1813 (2011) 1465–1474carefully explored which anti-apoptotic Bcl-2 family proteins play a
critical role on PaCa apoptosis by siRNA-mediated knock-down of Bcl-
2, Bcl-xL, and Mcl-1. We conﬁrmed a marked induction of apoptosis
following knock-down of Mcl-1, whereas Bcl-2 and Bcl-xL knock-
down resulted only in minimal induction of apoptosis. However,
double knock-down of Mcl-1 and Bcl-xL in MIA PaCa-2 cells had a
signiﬁcantly more robust effect on apoptosis than Mcl-1 knock-down
alone. Among the anti-apoptotic Bcl-2 family proteins, Mcl-1 seems to
play the most critical pro-survival role in pancreatic cancer cells (as
evident by the single knock-down of each protein). However, onceMcl-1 is knocked-down, additional reduction of other anti-apoptotic
Bcl-2 family members, such as Bcl-xL, greatly elevates the induction of
cell death. To our knowledge, this is the ﬁrst report comparing the
effect of three anti-apoptotic Bcl-2 family proteins in PaCa.
In this study, we demonstrated that baicalein treatment signiﬁ-
cantly induced apoptosis through a caspase-dependent mechanism.
We observed a close correlation between baicalein-induced apoptosis
and decrease in Mcl-1 expression, and over-expression of Mcl-1
confers resistance against baicalein treatment. It is of note that
baicalein did not change expression of Bcl-xL proteins in any
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1473H. Takahashi et al. / Biochimica et Biophysica Acta 1813 (2011) 1465–1474pancreatic cancer cell line. In addition, genetic knock-down of Mcl-1
by siRNA signiﬁcantly abrogated the apoptosis-inducing effect of
baicalein, suggesting that the pro-apoptotic effect of baicalein was
mediated through reduction of Mcl-1. However, baicalein still had an
additional (albeit signiﬁcantly less robust) effect on apoptosis in cells,
in whichMcl-1 was knocked-down. The reasons for this phenomenon
may include the lack of complete knock-down of Mcl-1 by siRNA and
consequently an additional effect of baicalein on the remaining Mcl-1
expression, or alternative pathways (independent of Mcl-1) of
apoptosis induction by baicalein.BH3-only proteins are classiﬁed in activator BH3-only protein and
sensitizer BH3-only protein [3]. Activator BH3-only proteins can
directly activate pro-apoptotic multi-domain molecules Bak/Bax, but
the effect of sensitizer BH3-only protein is indirect; sensitizer BH3-
only proteins lower the threshold of apoptosis by occupying the
binding pocket of anti-apoptotic proteins, such as Bcl-xL or Bcl-2 [3].
In this report, baicalein reduced Bim and PUMA, and induced
sensitizer BH3-only protein Bad. However Bad knock-down by
siRNA did not reverse baicalein-induced apoptosis, indicating that
Bad is not involved in baicalein-induced apoptosis. In addition to the
1474 H. Takahashi et al. / Biochimica et Biophysica Acta 1813 (2011) 1465–1474increased expression of Bad, baicalein also increased phosphorylation
of Bad on Ser112, which is important for translocation of Bad from the
mitochondrial membrane to the cytosol, thereby inactivating the pro-
apoptotic function of Bad. Again, this ﬁnding suggests that the pro-
apoptotic effects of baicalein in pancreatic cancer cells do not involve
activation of Bad. We observed a strong binding between Mcl-1 and
Bak in PaCa cells. Bak has been reported to play a critical role on UV- or
chemotherapeutic agent-induced apoptosis. To clarify the involve-
ment of Bak in this setting, further studies are necessary to delineate
the role of Bak in baicalein-induced apoptosis in PaCa cells. Our results
suggest the following possible scenario: In untreated pancreatic
cancer cells, Mcl-1 exerts a strong survival function by binding to pro-
apoptotic Bcl-2 molecules, i.e. Bak. Baicalein leads to reduced
expression on Mcl-1, thereby possibly freeing pro-apoptotic Bcl-2
proteins, i.e. Bak, from their suppression by Mcl-1.
Mcl-1 is considered as a promising therapeutic target because of its
short half-life and multiple mechanisms regulating its expression. So
far, some therapeutic approaches have been reported to abrogate the
anti-apoptotic function of Mcl-1. It is reported that some BH3
mimetic, such as obatoclax, can bind to and disable Bcl-2 family
proteins, including Mcl-1 [33]. Recently, the multi-kinase inhibitor
sorafenib has been reported to down-regulate Mcl-1 protein
expression through a translational mechanism [34]. Furthermore,
certain natural products, such as piceatannol, have been shown to
reduce Mcl-1 protein expression [35]. Based on our data, we propose
that baicalein may be a therapeutic tool targeting Mcl-1. Importantly,
SB and SB-derived polyphenols are known to have almost no or very
minimal toxicity in vitro and in vivo[11], rendering them intriguing
drug candidates.
In summary, we demonstrated that the pro-apoptotic effect of
baicalein in PaCa cells is mediated through reducing the expression of
the pro-survival protein Mcl-1, at least partially via a transcriptional
mechanism. Mcl-1 is highly expressed in PaCa cell lines and down-
regulation of Mcl-1 by siRNA showed a strong pro-apoptotic effect.
These data suggest that baicalein may represent a promising
therapeutic agent in PaCa and may have a beneﬁcial value as a
sensitizing agent for standard chemotherapeutic drugs by targeting a
major survival molecule.
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